Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE)

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped The study enrollment was halted on 14-Jun-2020. The study was not resumed and was terminated on 06-Jun-2024. Participants are no longer being examined or receiving intervention. Sponsor is no longer pursuing clinical evidence from the ADVANCE study.

Conditions

Intracranial Aneurysm

Interventions

DEVICE: Pipeline™ Vantage Embolization Device with Shield Technology™

Sponsor

Medtronic Neurovascular Clinical Affairs